LXRX SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0000315066-26-002771
LXRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. An institutional holder filed an amended Schedule 13G disclosing a passive ownership position in Lexicon Pharmaceuticals (LXRX). The stock moved +8.8% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G disclosing a passive ownership position in Lexicon Pharmaceuticals (LXRX). The filing indicates a change in the holder's previously reported stake.
Key details
How LXRX stock reacted
Close before
$1.48
Nov 4, 2026
First close after
+8.78%
$1.61
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for LXRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LXRX?
Click hereFrequently asked questions
What did LXRX file with the SEC on Nov 5, 2026?
LXRX filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G disclosing a passive ownership position in Lexicon Pharmaceuticals (LXRX). The filing indicates a change in the holder's previously reported stake.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did LXRX stock react to this filing?
LXRX closed at $1.48 before the filing and $1.61 on Nov 5, 2026 (+8.78%).
Other LXRX SEC filings
Get alerts when LXRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days